Screening/Prevention Prostate Cancer

Midlife PSA Levels Correlate to Risk of Future Lethal Prostate Cancer (08-15-2016)

A baseline prostate-specific antigen (PSA) level among men at midlife appears to be highly correlated with the risk of developing lethal prostate cancer within their lifetimes. These results were recently published in the Journal of Clinical Oncology. Prostate... Continue Reading

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (05-25-2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing and genetic counseling service, today announced its... Continue Reading

Omega-3 Fatty Acids Linked to Increased Risk of Prostate Cancer (08-23-2013)

Omega-3 fatty acids may be linked to an increased risk of prostate cancer, according to the results of a study published in the Journal of the National Cancer Institute. Other than skin cancer, prostate cancer is the most commonly diagnosed cancer in... Continue Reading

Prostate Cancer Screening Can Take a Toll on Quality of Life (12-19-2012)

Screening for prostate cancer carries some risks and can affect quality of life. Considering these risks is important when making the decision about whether to be screened. The results of a study that assessed both the potential benefits of screening... Continue Reading

Aspirin and Cancer Risk and Mortality (09-17-2012)

Aspirin and cancer risk is in the news again—and the link is still unclear. Two studies published early online in the Journal of Clinical Oncology evaluated the relationship between aspirin and cancer risk—one indicated that aspirin does not appear... Continue Reading

New Screening Method May Help Diagnose Undetectable Prostate Cancer (08-16-2012)

Men with persistently increased or fluctuating prostate specific antigen (PSA) levels and a negative prostate biopsy may benefit from a new prostate cancer screening method that uses the combination of a novel drug therapy plus changes in PSA levels over... Continue Reading

PSA Testing May Be Appropriate for Some Men (07-25-2012)

The American Society of Clinical Oncology (ASCO) has released a Provisional Clinical Opinion (PCO) suggesting that that men with a longer life expectancy—those with at least 10 more years to live—discuss with their physician the potential risks and... Continue Reading

Side Effects of Prostate Cancer Treatment Persist Long-Term (07-5-2012)

Men who are treated for prostate cancer may continue to suffer from side effects 10 years after treatment, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, more than 192,000 men are diagnosed... Continue Reading

Number of Cancer Survivors Will Grow to 18 Million by 2022 (06-25-2012)

There will be nearly 18 million cancer survivors in the United States by 2022, according to a report by the American Cancer Society and the National Cancer Institute: Cancer Treatment & Survivorship Facts & Figures[1] and an accompanying journal... Continue Reading

Prostate Screening Not Recommended for Older Men (06-1-2012)

The U.S. Preventive Services Task Force (USPSTF) recently drafted a grade D recommendation against prostate-specific antigen (PSA) screening for prostate cancer; however, it is unclear how this will affect screening practices since their previous recommendation... Continue Reading

Next Page »